Clinical Evaluation - ISO 14155:2026 (ANVISA, FDA and CE Mark)
Clinical evaluation of medical devices under ISO 14155:2026, with a Clinical Evaluation Plan (CEP), Clinical Evaluation Report (CER) and PMCF.
- Duration
- 24 hours
- Format
- EAD
About the course
A course focused on Clinical Evaluation of medical devices based on ISO 14155:2026, integrating ANVISA, FDA and MDR 745/2017 (Annex XIV) requirements, covering the Clinical Evaluation Plan (CEP), Clinical Evaluation Report (CER), systematic literature searching and PMCF. The course includes a PDF handbook with editable note pages, a workbook and a continuous practical case (a fictitious hip prosthesis) across the five modules.
What you will learn
Module 01Clinical evaluation fundamentals
Concepts, risk classification and the role of clinical evaluation in the technical dossier.
Module 02Clinical evaluation planning
Preclinical basis and definition of the plan's scope and strategy.
Module 03Clinical evidence and literature
Searching, selecting and critically appraising published data.
Module 04Post-market and clinical investigation
Use of post-market data and clinical study data.
Module 05Good practice in clinical investigation
ISO 14155 requirements for studies with medical devices.
Learning objective
Prepare participants to structure medical device clinical evaluation in accordance with global best practice, producing CEPs and CERs that can be defended before regulatory authorities and notified bodies.
Who this course is for
Regulatory Affairs, Clinical Research, Medical Writing and Quality professionals, and consultants involved in medical device clinical evaluation.
Your instructor

Drª. Juliane Rossato PhD
Biomedical scientist with a PhD in clinical and regulatory evaluation of medical devices. More than 15 years in clinical research and ANVISA submissions. Co-inventor of an international patent. Biomedical scientist with a PhD in clinical and regulatory evaluation of medical devices More than 15 years in clinical and preclinical research Specialist in ANVISA submissions and projects involving stents, TAVI and nanotechnology Co-inventor of an international patent and leader of FINEP/TECNOVA-RS projects Expertise in ISO 14155:2020, MDR 2017/745 and RDC 848/2024 Clinical and biological evaluation Consultant and Instructor at HSC Global